What Does a High or Low Chlamydia and Gonorrhea Result Mean?

Medical & affiliate disclosure: CTX Stat provides educational laboratory information and is not a substitute for professional medical advice, diagnosis, or treatment. CTX Stat may receive compensation from some outbound provider links when an affiliate program is active; provider comparisons and rankings are based on consumer fit, effective cost, access, policies, and reputation—not commission.

Quick take

Why “high” and “low” can be confusing on chlamydia and gonorrhea tests

If you searched for a high low chlamydia gonorrhea test, you may be trying to understand whether your result shows a mild infection, a severe infection, or a bacterial count. For the standard tests used for chlamydia and gonorrhea, that is usually not how the result works.

Most modern chlamydia and gonorrhea tests are nucleic acid amplification tests, often abbreviated NAATs. These tests look for genetic material from Chlamydia trachomatis or Neisseria gonorrhoeae. The CDC describes NAATs as the recommended and most sensitive tests for chlamydia, and the CDC also describes NAATs as highly useful for detecting gonorrhea at urogenital and certain extragenital sites.

Because NAATs are usually qualitative tests, the main question is whether the organism was detected or not detected. A “detected” result does not usually tell you how much bacteria is present, how long you have had the infection, how contagious you are, or whether symptoms will be mild or severe. Likewise, a “not detected” result is not a “low” value. It means the lab did not detect the organism in that specimen under the test conditions.

Common result wording and what it means

Result wording	Plain-English meaning	What to do next
Positive	The organism was found in the specimen tested.	Contact the clinician, clinic, or testing service promptly for treatment instructions and partner guidance.
Detected	Genetic material from chlamydia or gonorrhea was detected.	Treat this like a positive result unless your clinician or lab gives a different interpretation.
Negative	The organism was not found in the specimen tested.	If exposure was recent, symptoms continue, or the wrong site was tested, ask whether repeat or site-specific testing is needed.
Not detected	The lab did not detect chlamydia or gonorrhea in that specimen.	Consider whether the sample matched your exposure sites, especially if oral or anal exposure occurred.
Equivocal, indeterminate, or inconclusive	The lab could not confidently call the result positive or negative.	Repeat testing is commonly needed; follow the lab or clinician’s instructions.
Invalid or insufficient sample	The test could not be completed reliably, often because of collection, transport, or technical issues.	Submit a new specimen as directed.

How chlamydia and gonorrhea are reported on a combined panel

Chlamydia and gonorrhea are often ordered together because the same specimen can frequently be tested for both organisms. The U.S. Preventive Services Task Force notes that NAATs can test for both infections using the same specimen, depending on the site and test platform.

Even when ordered together, the two results are separate. You might see:

• Chlamydia detected; gonorrhea not detected. This suggests chlamydia infection was found, but gonorrhea was not found in the tested specimen.
• Chlamydia not detected; gonorrhea detected. This suggests gonorrhea infection was found, but chlamydia was not found in that specimen.
• Both detected. This indicates both infections were found in the sample. Treatment decisions should address both organisms.
• Both not detected. Neither organism was found in the tested specimen, although timing and exposure site still matter.

One positive and one negative result is common enough that it should not be considered a lab contradiction. The organisms are different, and exposure does not guarantee both infections are present.

What a positive chlamydia result means

A positive chlamydia result means the test detected Chlamydia trachomatis in the sample. Chlamydia can infect the cervix, urethra, rectum, throat, and, less commonly, other sites. Many people have no symptoms, which is why screening is important for groups at higher risk.

Symptoms, when present, can include pain or burning with urination, abnormal vaginal or penile discharge, pelvic or lower abdominal pain, testicular pain, rectal discomfort, rectal discharge, or bleeding. However, symptoms alone cannot reliably confirm or rule out chlamydia. A positive lab result should be taken seriously even if you feel well.

CDC treatment guidance explains that chlamydial infection is treatable with appropriate antibiotics and includes specific recommendations for nonpregnant adults, pregnant patients, and certain anatomic sites. Treatment choice can depend on pregnancy status, allergies, medication interactions, and whether rectal infection is suspected or confirmed. Avoid trying to self-treat with leftover antibiotics; incomplete or incorrect treatment can fail and may delay proper care.

What a positive gonorrhea result means

A positive gonorrhea result means the test detected Neisseria gonorrhoeae in the sample. Gonorrhea can infect the urethra, cervix, rectum, throat, and eyes. Like chlamydia, it can be asymptomatic, especially at cervical, rectal, and throat sites.

Symptoms may include burning with urination, discharge, pelvic pain, testicular pain, rectal symptoms, or sore throat after oral exposure. But a throat infection may have no symptoms, and a negative urine test would not necessarily detect a throat infection.

Gonorrhea treatment is especially important to coordinate with a clinician because of antibiotic-resistance concerns. The CDC’s gonorrhea guidance emphasizes specific recommended regimens and notes that culture and antimicrobial susceptibility testing are important when treatment failure is suspected. A NAAT can detect gonorrhea, but it does not usually tell which antibiotic the strain is susceptible to.

What a negative result means—and what it does not mean

A negative or “not detected” result means the lab did not detect chlamydia or gonorrhea in the specimen tested. If the test was done at the correct site, at an appropriate time after exposure, and the sample was collected properly, a negative result is reassuring.

However, a negative result is not always the final answer. Reasons a person could still need follow-up include:

• Testing too soon after exposure. There can be a short period after exposure when an infection is not yet detectable. If you tested very soon after a possible exposure, ask when repeat testing makes sense.
• Wrong anatomic site tested. Urine does not evaluate the throat or rectum. A vaginal swab does not evaluate the throat. If exposure occurred at more than one site, site-specific testing may be needed.
• Specimen collection problems. For urine NAATs, many instructions call for first-catch or first-void urine, meaning the first part of the urine stream, not a midstream clean-catch sample. Swab tests also require correct technique.
• Recent antibiotic use. Antibiotics taken for another reason may affect test results or symptoms. Tell your clinician about recent medications.
• Symptoms from another cause. Burning, discharge, pelvic pain, rectal symptoms, or sore throat may be due to another STI or non-STI condition even when chlamydia and gonorrhea are negative.

Why site-specific results matter

Chlamydia and gonorrhea results are only as broad as the sites tested. The CDC notes that rectal and oropharyngeal chlamydia can be diagnosed by testing at the anatomic exposure site, and gonorrhea NAATs may be used for urogenital and certain extragenital specimens depending on the test platform.

Exposure or concern	Often relevant specimen	Important limitation
Vaginal sex, cervical infection concern	Vaginal swab, cervical swab, or urine depending on test and setting	A urine-only test may be less optimal than a vaginal swab for some screening situations.
Penile/urethral infection concern	First-catch urine or urethral/meatal swab depending on test	Midstream urine may not be the intended specimen for many STI NAATs.
Receptive anal sex or rectal symptoms	Rectal swab	Urine or vaginal testing can miss rectal infection.
Receptive oral sex or throat exposure	Throat/pharyngeal swab	Throat infections can be asymptomatic; urine testing does not assess the throat.

If your results do not match your exposure history, ask the ordering clinician or testing service whether additional site testing is appropriate. This is particularly important for men who have sex with men, people with rectal or throat exposure, and anyone with persistent symptoms despite a negative urogenital result.

Positive result but no symptoms: is that possible?

Yes. Chlamydia and gonorrhea frequently cause no symptoms. A positive result without symptoms still matters because untreated infection can be transmitted to partners and may lead to complications. In people with a uterus, untreated infection can ascend into the upper reproductive tract and contribute to pelvic inflammatory disease. In pregnancy, these infections can create risks that require prompt clinical attention. In people with testes, complications can include epididymitis. Gonorrhea can rarely spread beyond the original site and cause disseminated infection.

Because symptoms are unreliable, screening recommendations focus on age, anatomy, pregnancy status, sexual practices, and risk factors. The CDC’s STI screening recommendations include annual screening for sexually active women under 25 and screening for older women with increased risk, with additional site-based screening considerations for certain exposures and populations.

Could a positive result be false?

False positives are uncommon with well-validated NAATs, but no test is perfect. The likelihood that a positive result is truly positive depends on the test used, the specimen type, the quality of collection, and the chance of infection before testing. Lab contamination, specimen mix-up, or rare test cross-reactivity can occur, but they are not the usual explanation for a positive result.

If a result is unexpected, do not ignore it. Contact the ordering clinician, clinic, or test provider. They may review your exposure history, symptoms, collection method, and whether confirmatory or repeat testing is appropriate. For gonorrhea, culture may be particularly important if treatment failure is suspected because culture can allow antimicrobial susceptibility testing, whereas NAAT generally cannot.

Could a negative result be false?

Yes, a false negative can occur. Common practical reasons include testing before the organism is detectable, testing the wrong site, not following collection instructions, or using a specimen type that is not optimal for that person’s anatomy or exposure.

For example, a person with receptive oral exposure may have throat gonorrhea but a negative urine test. A person with receptive anal exposure may have rectal chlamydia but a negative vaginal or urine result. This does not mean the lab was careless; it means the specimen answered a narrower question.

Repeat testing may be appropriate if you have ongoing symptoms, a partner who tested positive, a recent high-risk exposure, or a specimen problem. If you were notified that a partner has chlamydia or gonorrhea, ask a clinician whether you should be treated even if your test is negative, because partner-management recommendations depend on exposure timing and clinical context.

What to do after a positive result

A positive result is actionable. The exact next step depends on which infection was found, your pregnancy status, medication allergies, symptoms, and the site of infection.

1. Contact a healthcare professional or the testing service promptly. Chlamydia and gonorrhea are curable with the right antibiotics, but the regimen must match the infection and clinical situation. The CDC provides patient-facing next-step guidance for people who test positive for gonorrhea or chlamydia.
2. Avoid sex until treatment guidance is complete. Your clinician or clinic can tell you how long to avoid sexual contact and when it is safe to resume. Partners may also need treatment before sex resumes to reduce reinfection.
3. Notify recent sex partners. This can feel uncomfortable, but it helps prevent reinfection and further spread. Some health departments and clinics can help with confidential partner notification.
4. Ask whether you need testing for other STIs. A positive chlamydia or gonorrhea test can be a reason to consider HIV, syphilis, trichomoniasis, hepatitis, or other testing based on exposure and risk.
5. Plan retesting. Reinfection is common enough that retesting is often recommended about 3 months after treatment. This is different from a test of cure.

Test of cure vs. retesting: what is the difference?

A test of cure checks whether the original infection cleared after treatment. Retesting later checks for reinfection, which can happen if a partner was not treated or a new exposure occurred.

Follow-up type	Purpose	When it may be used
Test of cure	Confirm the treated infection is gone	Often recommended in pregnancy after chlamydia treatment and for pharyngeal gonorrhea; may be used when symptoms persist or treatment failure is a concern.
Retesting	Look for reinfection after treatment	Commonly recommended around 3 months after treatment for chlamydia or gonorrhea.

Timing matters. Testing too soon after treatment can sometimes detect leftover genetic material rather than active infection, especially with NAATs. The CDC’s chlamydia guidance cautions against using NAAT less than 4 weeks after completing therapy in nonpregnant people unless directed, because nonviable organisms can contribute to false-positive results. For pharyngeal gonorrhea, CDC guidance recommends test of cure 7–14 days after treatment, while noting that testing at 7 days can increase the chance of a false-positive NAAT.

Preparing for repeat or first-time testing

Follow the instructions from the lab, clinic, or home-collection kit because details vary by test. General preparation points include:

• Use the right specimen type. If the order is for urine, swab, throat, or rectal testing, collect exactly what is requested.
• For urine testing, follow first-catch instructions. STI urine testing often requires the first part of the urine stream. This is different from a clean-catch urine culture used for some urinary tract infection testing.
• Do not douche or use intravaginal products before a vaginal swab unless instructions say they are allowed. These products may interfere with some testing or make collection less reliable.
• Be honest about exposure sites. A clinician cannot choose the right swabs unless they know whether oral, vaginal, anal, or genital contact occurred.
• Tell the clinician about antibiotics. Recent antibiotic use can affect symptoms and may influence interpretation or timing.

At-home sample collection is also an option for some adults. In 2023, the FDA granted marketing authorization for the first chlamydia and gonorrhea test with at-home sample collection. If using an at-home option, check that the test is appropriate for your age, anatomy, exposure site, state availability, and whether clinical support is included for positive results.

When to seek urgent care

Many positive chlamydia or gonorrhea results can be managed through a clinic, primary care office, sexual health clinic, urgent care, telehealth service, or health department. However, seek urgent medical care if you have severe pelvic or lower abdominal pain, fever, vomiting, testicular pain or swelling, severe rectal pain, eye pain or discharge after possible exposure, rash or joint pain with suspected gonorrhea, or if you are pregnant and have symptoms or a positive result.

Also seek prompt care if you were sexually assaulted, if a minor has a positive STI result, or if you are concerned about coercion or safety. These situations require specialized medical and support resources beyond routine result interpretation.

Cost and access considerations

Chlamydia and gonorrhea testing may be available through primary care offices, OB-GYN practices, urgent care clinics, sexual health clinics, student health centers, public health departments, and at-home collection services. Your out-of-pocket cost can vary based on insurance, visit fees, lab fees, specimen sites, and whether treatment is included.

If you are comparing self-pay options, compare the total effective cost, not just the advertised lab price. Ask whether the price includes the provider order, specimen collection, lab processing, results review, mandatory service fees, and follow-up support for positive results. If treatment is offered through the same service, ask whether medication costs are included or billed separately. Public health clinics may offer low-cost or no-cost testing depending on location and eligibility.

Bottom line

A chlamydia or gonorrhea result usually should not be read as “high” or “low.” For most people, the meaningful interpretation is whether each organism was detected or not detected in the specific specimen tested. A positive result deserves prompt treatment and partner follow-up. A negative result is reassuring only for the site and timing tested. If your result is unexpected, symptoms continue, a partner tested positive, or your exposure sites were not fully tested, the safest next step is to review the result with a qualified healthcare professional or sexual health clinic.

 

Frequently asked questions

Can a chlamydia or gonorrhea test be high or low?

Usually no. Standard NAAT results are generally qualitative: positive or negative, detected or not detected. They do not usually report a bacterial quantity, so “high” and “low” are not the right framework for most results.

Does a positive result mean I recently got infected?

Not necessarily. A positive result shows the organism was detected in the specimen, but it usually cannot tell exactly when infection occurred. Some people have no symptoms for long periods, and symptoms may appear days to weeks after exposure or not at all.

Can I test positive after being treated?

Yes. A positive result after treatment could mean reinfection, treatment failure, testing too soon, or leftover genetic material detected by NAAT. Timing and symptoms matter. Ask the treating clinician when repeat testing should be done.

Why did my partner test positive but I tested negative?

Possible explanations include different exposure timing, infection at a site that was not tested, spontaneous clearance, recent antibiotic exposure, collection differences, or a false negative or false positive. A clinician can help decide whether repeat testing or treatment is appropriate.

Is urine or swab testing better?

It depends on anatomy, exposure site, and test platform. CDC guidance identifies first-catch urine as an optimal urogenital specimen for men and vaginal swabs as optimal for women for many NAAT screening situations. Rectal or throat exposure requires rectal or throat swabs to evaluate those sites.

Can chlamydia and gonorrhea go away without treatment?

Symptoms may improve or disappear, but that does not mean the infection is gone or that complications cannot occur. Because both infections are treatable and transmissible, a positive result should be managed with appropriate medical treatment.

Should I get tested for other STIs if one result is positive?

Often yes. A positive chlamydia or gonorrhea result can indicate exposure risk for other STIs. Ask about HIV, syphilis, hepatitis, trichomoniasis, and other testing based on your sexual history, symptoms, and local recommendations.

Sources

• CDC: Chlamydial Infections — STI Treatment Guidelines
• CDC: Gonococcal Infections Among Adolescents and Adults — STI Treatment Guidelines
• CDC: STI Screening Recommendations
• CDC: Next Steps After Testing Positive for Gonorrhea or Chlamydia
• USPSTF: Chlamydia and Gonorrhea Screening Recommendation
• FDA: Marketing Authorization for Chlamydia and Gonorrhea Test With At-Home Sample Collection